Since this medicine is usually administered by a qualified health care professional in the clinical/hospital setting, the likelihood of a missed dose is very low.
Since this medicine is usually administered by a qualified health care professional in the clinical/hospital setting, the likelihood of an overdose is very low. However, emergency medical treatment will be instituted by the doctor if an overdose is suspected.
Enoxaparin (severe)
Alteplase (severe)
Clopidogrel (severe)
Warfarin (severe)
Ibuprofen (moderate)
Abciximab (severe)
This medicine is used in combination with heparin to decrease the risk of death and a new episode of a heart attack in patients suffering from non-ST elevation acute coronary syndrome (NSTE-ACS), including patients who are to be managed medically and those undergoing percutaneous transluminal coronary angioplasty (PTCA) or atherectomy.
Unusual bleeding or bruising
Abdominal or stomach pain
Swelling of the hands, ankles, feet, or lower legs
Dizziness and fainting
Black or tarry stools
Headache
Fast or irregular heartbeat
Bleeding gums
Pinpoint red spots on skin
Unusual tiredness or weakness
Presence of blood in cough
This medicine is not recommended for use in patients with a known allergy to AGGRASTAT 0.25mg|ml Injection 50ml or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients with a history of bleeding disorders due to blood coagulation issues (bleeding diathesis) or active abnormal bleeding within the previous 30 days due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients suffering from severe hypertension (high blood pressure levels more than 200/110 mm Hg) that is not adequately controlled using appropriate medication due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with a history of stroke within the past 30 days or any history of hemorrhagic stroke (an emergency condition where blood vessels rupture within the brain) due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients who have undergone major surgery within the preceding 6 weeks due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with acute pericarditis (inflammation of the protective layer surrounding the heart, pericardium) due to the increased risk of worsening of the patient’s condition.